234
Views
65
CrossRef citations to date
0
Altmetric
Original Research

Epidemiology Of Vestibular Schwannomas – Prospective 40-Year Data From An Unselected National Cohort

ORCID Icon, , ORCID Icon, &
Pages 981-986 | Published online: 08 Nov 2019

References

  • Stangerup S-E, Tos M, Caye-Thomasen P, Tos T, Klokker M, Thomsen J. Increasing annual incidence of vestibular schwannoma and age at diagnosis. J Laryngol Otol. 2004;118(8):622–627. doi:10.1258/002221504191798915453938
  • Thomsen J, Tos M, Harmsen A, Riishede J, Thornval G. Surgery of acoustic neuromas. Preliminary experience with a translabyrinthine approach. Acta Neurol Scand. 1977;56(4):277–290.920109
  • Tos M, Thomsen J. Epidemiology of acoustic neuromas. J Laryngol Otol. 1984;98(7):685–692. doi:10.1017/s00222151001472926747450
  • Tos M, Thomsen J, Charabi S. Incidence of acoustic neuromas. Ear Nose Throat J. 1992;71(9):391–393.1425377
  • Tos M, Charabi S, Thomsen J. Incidence of vestibular schwannomas. Laryngoscope. 1999;109(5):736–740. doi:10.1097/00005537-199905000-0001110334223
  • Stangerup S-E, Tos M, Thomsen J, Caye-Thomasen P. True incidence of vestibular schwannoma? Neurosurgery. 2010;67(5):1335–1340. discussion 1340. doi:10.1227/NEU.0b013e3181f2266020871439
  • Stangerup S-E, Caye-Thomasen P. Epidemiology and natural history of vestibular schwannomas. Otolaryngol Clin North Am. 2012;45(2):257–268, vii. doi:10.1016/j.otc.2011.12.00822483814
  • Nestor JJ, Korol HW, Nutik SL, Smith R. The incidence of acoustic neuromas. Arch Otolaryngol Head Neck Surg. 1988;114(6):680. doi:10.1001/archotol.1988.01860180094042
  • Frohlich AM, Sutherland GR. Epidemiology and clinical features of vestibular schwannoma in Manitoba, Canada. Can J Neurol Sci. 1993;20(2):126–130. doi:10.1017/s03171671000476858334574
  • Evans DGR, Moran A, King A, Saeed S, Gurusinghe N, Ramsden R. Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought. Otol Neurotol. 2005;26(1):93–97.15699726
  • Mirz F, Pedersen CB, Fiirgaard B, Lundorf E. Incidence and growth pattern of vestibular schwannomas in a Danish county, 1977–98. Acta Otolaryngol Suppl. 2000;543:30–33. doi:10.1080/00016480045388310908969
  • Carlson ML, Habermann EB, Wagie AE, et al. The changing landscape of vestibular schwannoma management in the United Statesâ—a shift toward conservatism. Otolaryngol Head Neck Surg. 2015;153(3):440–446. doi:10.1177/019459981559010526129740
  • Kshettry VR, Hsieh JK, Ostrom QT, Kruchko C, Barnholtz-Sloan JS. Incidence of vestibular schwannomas in the United States. J Neurooncol. 2015;124(2):223–228. doi:10.1007/s11060-015-1827-926024654
  • Propp JM, McCarthy BJ, Davis FG, Preston-Martin S. Descriptive epidemiology of vestibular schwannomas. Neuro-Oncology. 2006;8(1):1–11. doi:10.1215/S152285170400109716443943
  • Kleijwegt M, Ho V, Visser O, Godefroy W, van der Mey A. Real incidence of vestibular schwannoma? Estimations from a national registry. Otol Neurotol. 2016;37(9):1411–1417. doi:10.1097/MAO.000000000000116927525713
  • Koo M, Lai J-T, Yang EY-L, Liu T-C, Hwang J-H. Incidence of vestibular schwannoma in taiwan from 2001 to 2012: a population-based national health insurance study. Ann Otol Rhinol Laryngol. 2018;127(10):694–697. doi:10.1177/000348941878838530032646
  • Marinelli JP, Lohse CM, Carlson ML. Incidence of vestibular schwannoma over the past half-century: a population-based study of Olmsted County, Minnesota. Otolaryngol Head Neck Surg. 2018;159(4):717–723. doi:10.1177/019459981877062929712512
  • Kanzaki J, Tos M, Sanna M, Moffat DA, Monsell EM, Berliner KI. New and modified reporting systems from the consensus meeting on systems for reporting results in vestibular schwannoma. Otol Neurotol. 2003;24(4):642–648. discussion 648–649.12851559
  • Schwartz M, Fisher L. Incidence and clinical characteristics of acoustic neuroma in beverly hills. Skull Base. 2006;16(S 1):A040. doi:10.1055/s-2006-958307
  • Stepanidis K, Kessel M, Caye-Thomasen P, Stangerup S-E. Socio-demographic distribution of vestibular schwannomas in Denmark. Acta Otolaryngol. 2014;134(6):551–556. doi:10.3109/00016489.2014.89029324655069
  • Sass HCR, Borup R, Alanin M, Nielsen FC, Cayé-Thomasen P. Gene expression, signal transduction pathways and functional networks associated with growth of sporadic vestibular schwannomas. J Neurooncol. 2017;131(2):283–292. doi:10.1007/s11060-016-2292-927752882
  • Burkhart CG. Herpes and acoustic neuromas: is there a cause and effect to observe? Med Hypotheses. 2010;74(6):1013–1014. doi:10.1016/j.mehy.2010.01.01020153934
  • Bhimrao SK, Maguire J, Garnis C, et al. Lack of association between human herpesvirus and vestibular schwannoma: analysis of 121 cases. Otolaryngol Head Neck Surg. 2015;152(3):513–517. doi:10.1177/019459981456351725560404
  • Corona AP, Ferrite S, da Silva Lopes M, Rêgo MAV. Risk factors associated with vestibular nerve schwannomas. Otol Neurotol. 2012;33(3):459–465. doi:10.1097/MAO.0b013e3182487fee22377646
  • Berkowitz O, Iyer AK, Kano H, Talbott EO, Lunsford LD. Epidemiology and environmental risk factors associated with vestibular schwannoma. World Neurosurg. 2015;84(6):1674–1680. doi:10.1016/j.wneu.2015.07.00726171891
  • Dilwali S, Kao S-Y, Fujita T, Landegger LD, Stankovic KM. Nonsteroidal anti-inflammatory medications are cytostatic against human vestibular schwannomas. Transl Res. 2015;166(1):1–11. doi:10.1016/j.trsl.2014.12.00725616959
  • Kandathil CK, Cunnane ME, McKenna MJ, Curtin HD, Stankovic KM. Correlation between aspirin intake and reduced growth of human vestibular schwannoma: volumetric analysis. Otol Neurotol. 2016;37(9):1428–1434. doi:10.1097/MAO.000000000000118027631829
  • Hunter JB, O’Connell BP, Wanna GB, et al. Vestibular schwannoma growth with aspirin and other nonsteroidal anti-inflammatory drugs. Otol Neurotol. 2017;38(8):1158–1164. doi:10.1097/MAO.000000000000150628692590
  • Marinelli JP, Lees KA, Tombers NM, Lohse CM, Carlson ML. Impact of aspirin and other NSAID use on volumetric and linear growth in vestibular schwannoma. Otolaryngol Head Neck Surg. 2019;160(6): 194599819827812. doi:10.1177/0194599819827812
  • Schoemaker MJ, Swerdlow AJ, Auvinen A, et al. Medical history, cigarette smoking and risk of acoustic neuroma: an international case-control study. Int J Cancer. 2007;120(1):103–110. doi:10.1002/ijc.2227217019705
  • Benson VS, Green J, Pirie K, Beral V. Cigarette smoking and risk of acoustic neuromas and pituitary tumours in the million women study. Br J Cancer. 2010;102(11):1654–1656. doi:10.1038/sj.bjc.660569520461083
  • Palmisano S, Schwartzbaum J, Prochazka M, et al. Role of tobacco use in the etiology of acoustic neuroma. Am J Epidemiol. 2012;175(12):1243–1251. doi:10.1093/aje/kwr46522517809
  • Chen M, Fan Z, Zheng X, Cao F, Wang L. Risk factors of acoustic neuroma: systematic review and meta-analysis. Yonsei Med J. 2016;57(3):776–783. doi:10.3349/ymj.2016.57.3.77626996581
  • Prochazka M, Feychting M, Ahlbom A, et al. Occupational exposures and risk of acoustic neuroma. Occup Environ Med. 2010;67(11):766–771. doi:10.1136/oem.2009.04788620581419
  • Schuz J, Steding-Jessen M, Hansen S, et al. Long-term mobile phone use and the risk of vestibular schwannoma: a Danish nationwide cohort study. Am J Epidemiol. 2011;174(4):416–422. doi:10.1093/aje/kwr11221712479
  • Fisher JL, Pettersson D, Palmisano S, et al. Loud noise exposure and acoustic neuroma. Am J Epidemiol. 2014;180(1):58–67. doi:10.1093/aje/kwu08124786799
  • Roswall N, Stangerup S-E, Cayé-Thomasen P, et al. Residential traffic noise exposure and vestibular schwannomaâ-a Danish case-control study. Acta Oncol. 2017;56(10):1310–1316. doi:10.1080/0284186X.2017.133792528609173
  • Ron E, Modan B, Boice JD, et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med. 1988;319(16):1033–1039. doi:10.1056/NEJM1988102031916013173432
  • Preston DL, Ron E, Yonehara S, et al. Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J Natl Cancer Inst. 2002;94(20):1555–1563. doi:10.1093/jnci/94.20.155512381708
  • Evans DGR, Birch JM, Ramsden RT, Sharif S, Baser ME. Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes. J Med Genet. 2006;43(4):289–294. doi:10.1136/jmg.2005.03631916155191
  • Pollock BE, Link MJ, Stafford SL, Parney IF, Garces YI, Foote RL. The risk of radiation-induced tumors or malignant transformation after single-fraction intracranial radiosurgery: results based on a 25-year experience. Int J Radiat Oncol Biol Phys. 2017;97(5):919–923. doi:10.1016/j.ijrobp.2017.01.00428333013